Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NNVC

NanoViricides (NNVC)

NanoViricides Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:NNVC
DateTimeSourceHeadlineSymbolCompany
2:22PMiHub NewswireFeatured1847 Announces $1.95 Million Repayment of Convertible Notes
02/16/20244:53PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NNVCNanoViricides Inc
02/14/20244:55PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NNVCNanoViricides Inc
01/19/20244:44PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NNVCNanoViricides Inc
12/04/20234:08PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:NNVCNanoViricides Inc
10/13/20234:30PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]AMEX:NNVCNanoViricides Inc
09/28/20234:44PMEdgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405AMEX:NNVCNanoViricides Inc
09/01/20234:46PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:NNVCNanoViricides Inc
07/06/202311:16AMInvestorsHub NewsWireClinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical NeedsAMEX:NNVCNanoViricides Inc
05/25/20234:34PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:NNVCNanoViricides Inc
05/08/20235:20PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)AMEX:NNVCNanoViricides Inc
05/04/20236:45AMGlobeNewswire Inc.NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York CityAMEX:NNVCNanoViricides Inc
02/14/20235:24PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:NNVCNanoViricides Inc
02/13/20235:02PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:NNVCNanoViricides Inc
12/23/20226:04AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:NNVCNanoViricides Inc
11/15/20224:32PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:NNVCNanoViricides Inc
11/04/20224:33PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:NNVCNanoViricides Inc
10/13/20225:13PMEdgar (US Regulatory)Annual Report (10-k)AMEX:NNVCNanoViricides Inc
09/29/202212:20PMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)AMEX:NNVCNanoViricides Inc
08/10/20226:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:NNVCNanoViricides Inc
05/16/20224:55PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:NNVCNanoViricides Inc
11/15/20214:55PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:NNVCNanoViricides Inc
11/15/20217:09AMInvestorsHub NewsWireNanoViricides Completes Oral Gummies and Lung Inhalation Formulations Development for its Non-Mutagenic, Safe, Broad-Spectrum COVID-19 Clinical Drug Candidate, NV-CoV-2AMEX:NNVCNanoViricides Inc
10/12/20216:16AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:NNVCNanoViricides Inc
10/11/20216:49AMInvestorsHub NewsWireNanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus ActivityAMEX:NNVCNanoViricides Inc
10/05/20216:45AMPR Newswire (US)NanoViricides Provides Update on Its Pan-Coronavirus COVID-19 Drug Development Program at Benzinga Healthcare Small Cap ConferenceAMEX:NNVCNanoViricides Inc
10/05/20216:45AMPR Newswire (US)NanoViricides Provides Update on Its Pan-Coronavirus COVID-19 Drug Development Program at Benzinga Healthcare Small Cap ConferenceAMEX:NNVCNanoViricides Inc
09/28/20214:32PMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)AMEX:NNVCNanoViricides Inc
09/22/20216:48AMInvestorsHub NewsWireSignificantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral DrugAMEX:NNVCNanoViricides Inc
09/22/20216:45AMPR Newswire (US)Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral DrugAMEX:NNVCNanoViricides Inc
 Showing the most relevant articles for your search:AMEX:NNVC